5NX Stock Overview
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Nexstim Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €8.12 |
| 52 Week High | €9.44 |
| 52 Week Low | €2.04 |
| Beta | 1.02 |
| 1 Month Change | 1.75% |
| 3 Month Change | 24.16% |
| 1 Year Change | 264.13% |
| 3 Year Change | 59.22% |
| 5 Year Change | 87.10% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5NX | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 3.8% | -3.9% | -1.4% |
| 1Y | 264.1% | -14.0% | 15.4% |
Return vs Industry: 5NX exceeded the German Medical Equipment industry which returned -13% over the past year.
Return vs Market: 5NX exceeded the German Market which returned 16.8% over the past year.
Price Volatility
| 5NX volatility | |
|---|---|
| 5NX Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: 5NX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5NX's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 40 | Mikko Karvinen | www.nexstim.com |
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s navigated transcranial magnetic stimulation (nTMS) technology utilizes 3D navigation for providing accurate and personalized targeting of the TMS to the specific areas of the brain. It also offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depressive disorder (MDD) and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim Plc Fundamentals Summary
| 5NX fundamental statistics | |
|---|---|
| Market cap | €59.16m |
| Earnings (TTM) | -€892.30k |
| Revenue (TTM) | €10.21m |
5.8x
P/S Ratio-66.3x
P/E RatioIs 5NX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5NX income statement (TTM) | |
|---|---|
| Revenue | €10.21m |
| Cost of Revenue | €1.83m |
| Gross Profit | €8.38m |
| Other Expenses | €9.27m |
| Earnings | -€892.30k |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Aug 15, 2025
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 82.04% |
| Net Profit Margin | -8.74% |
| Debt/Equity Ratio | 144.9% |
How did 5NX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/10 07:06 |
| End of Day Share Price | 2025/03/10 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nexstim Plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Antti Siltanen | Inderes Oy |
| Yilmaz Mahshid | Pareto Securities |